2-Bromobenzene-1,3-diol

Catalog No.: 
ACALNJ049
CAS No.: 
6751-75-3
Molecular Formula: 
C6H5BrO2
Molecular Weight: 
189.01
2-Bromobenzene-1,3-diol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g96%$111.00In stockInquiry
100g96%$389.00In stockInquiry
500g96%$1557.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromobenzene-1,3-diol
IUPAC Name2-bromobenzene-1,3-diol
MDL No.MFCD07779241
Molecular FormulaC6H5BrO2
Molecular Weight189.01
SMILESOC1=CC=CC(O)=C1Br
InChI KeyUOLPZAPIFFZLMF-UHFFFAOYSA-N
SynonymDTXSID00345488 | SY104422 | (+/-)-2-Octanol, ReagentPlus(R), >=99.5% (GC) | 2-Bromo-1,3-benzenediol | 2-Bromo-1,3-dihydroxybenzene | 2-Bromoresorcinol, 95% | B5737 | N-a-Boc-N-e-tosyl-L-lysine | 2-Bromoresorcinol | AKOS006285165 | CS-W015980 | STL556790 |
CAS No.6751-75-3
PubChem CID604810

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302+H312+H332-H315-H319-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACALNJ049 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACALNJ049 route product structure diagram
    ACALNJ0496751-75-3In Stock
Inquiry

2. ACALNJ049 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACALNJ049 route product structure diagram
    ACALNJ0496751-75-3In Stock
Inquiry

3. ACALNJ049 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACALNJ049 route product structure diagram
    ACALNJ0496751-75-3In Stock
Inquiry

Comments (0)